You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

relapsing remitting Multiple sclerosis

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Birmingham, Saint Louis (Glycemic

Not yet recruiting
  • Relapsing Remitting Multiple Sclerosis
  • Secondary Progressive Multiple Sclerosis
  • Glycemic load
  • +2 more
  • Birmingham, Alabama
  • +1 more
Jan 4, 2023

Multiple Sclerosis, Relapsing-Remitting, Caloric Restriction Trial in Pozzilli (Caloric restriction, Caloric restriction without

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Caloric Restriction
  • Caloric restriction
  • Caloric restriction without cow's milk and gluten
  • Pozzilli, IS, Italy
    Neuromed - Istituto Neurologico Mediterraneo Pozzilli
Jul 26, 2022

Relapsing-remitting Multiple Sclerosis Trial in Stockholm (Rituximab)

Active, not recruiting
  • Relapsing-remitting Multiple Sclerosis
  • Stockholm, Sweden
    Fredrik Piehl
Apr 8, 2022

Clinically Isolated Syndrome, Relapsing Remitting Multiple Sclerosis Trial in Iowa City (Therapeutic diet and lifestyle)

Active, not recruiting
  • Clinically Isolated Syndrome
  • Relapsing Remitting Multiple Sclerosis
  • Therapeutic diet and lifestyle
  • Iowa City, Iowa
    University of Iowa
Dec 14, 2021

Multiple Sclerosis Trial (Natalizumab)

Not yet recruiting
  • Multiple Sclerosis
  • (no location specified)
Jun 21, 2023

Relapsing Remitting Multiple Sclerosis Trial in Saint Louis (Intermittent fasting)

Completed
  • Relapsing Remitting Multiple Sclerosis
  • Intermittent fasting
  • Saint Louis, Missouri
    Washington University in St Louis
Apr 25, 2022

Relapsing Remitting Multiple Sclerosis (RRMS) Trial in Tehran (Pegylated interferon beta-1a, Interferon Beta-1A Prefilled

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis (RRMS)
  • Pegylated interferon beta-1a
  • Interferon Beta-1A Prefilled Syringe
  • Tehran, Iran, Islamic Republic of
    Sina Hospital
Feb 5, 2022

Implementation ofNovel Functional Eye-Tracking Biomarker for

Recruiting
  • Clinically Isolated Syndrome
  • Relapsing Remitting Multiple Sclerosis
  • Eye-tracking
  • Montréal, Quebec, Canada
    Montreal Neurological Institute and Hospital
Sep 2, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Washington (NeuroQuant, Automated Neuropsychological Assessment Matrices, EDSS)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • NeuroQuant
  • +3 more
  • Washington, District of Columbia
    The George Washignton University
Jan 4, 2023

Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam®

Withdrawn
  • Relapsing Remitting Multiple Sclerosis
  • monomethyl fumarate
  • (no location specified)
Nov 15, 2021

Multiple Sclerosis Trial in Shreveport (Interferon beta 1a, oral doxycycline)

Completed
Has Results
  • Multiple Sclerosis
  • Interferon beta 1a, oral doxycycline
  • Shreveport, Louisiana
    LSU Health Sciences Center Shreveport
Oct 11, 2022

Multiple Sclerosis Trial in Cambridge (Metformin and clemastine in combination, Placebo)

Recruiting
  • Multiple Sclerosis
  • Metformin and clemastine in combination
  • Placebo
  • Cambridge, United Kingdom
    Addenbrooke's Hospital
Jun 14, 2022

Visual Processing Speed and Objective Analysis of Ocular

Enrolling by invitation
  • Multiple Sclerosis
  • +3 more
  • Eye tracking
  • +3 more
  • Valladolid, Spain
    IOBA - Universidad de Valladolid
Jan 20, 2023

Tysabri in Early Relapsing Remitting Multiple Sclerosis

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis
  • Amadora, Portugal
  • +17 more
Apr 12, 2022

Relapsing Remitting Multiple Sclerosis Trial in Portland (3 mg Melatonin, 5 mg Melatonin)

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis
  • 3 mg Melatonin
  • 5 mg Melatonin
  • Portland, Oregon
    Providence MS Center
May 5, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Guangzhou (RC18 160mg, RC18 240mg)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • RC18 160mg
  • RC18 240mg
  • Guangzhou, Guangdong, China
    the Third Affiliated Hospital,Sun Yat-Sen University
Jan 7, 2022

Relapsing Remitting Multiple Sclerosis Trial (monomethyl fumarate 190 mg, dimethyl fumarate 240 mg)

Completed
Has Results
  • Relapsing Remitting Multiple Sclerosis
  • monomethyl fumarate 190 mg
  • dimethyl fumarate 240 mg
  • (no location specified)
Dec 5, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Dimethyl Fumarate, Peginterferon Beta-1a, Placebo)

Terminated
  • Multiple Sclerosis, Relapsing-Remitting
  • Dimethyl Fumarate
  • +2 more
  • Raleigh, North Carolina
  • +22 more
Nov 30, 2022

Upper Extremity Function in Multiple Sclerosis Advanced

Active, not recruiting
  • Multiple Sclerosis
  • +7 more
  • Tampa, Florida
    Carol and Frank Morsani Center for Advanced Healthcare
Nov 2, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Chisinau, Moldova, Republic of
    Republican Clinical Hospital, ARENSIA Exploratory Medicine
Jun 8, 2022

Tecfidera Capsules in Korean Relapsing-Remitting Multiple

Completed
  • Multiple Sclerosis, Relapsing-remitting
  • No Intervention
  • Cheonan, Chungcheongnam-do, Korea, Republic of
  • +19 more
May 4, 2022

Relapsing-Remitting Multiple Sclerosis Trial in Columbus (Step Tracking, Water Tracking)

Active, not recruiting
  • Relapsing-Remitting Multiple Sclerosis
  • Step Tracking
  • Water Tracking
  • Columbus, Ohio
    Department of Psychology, The Ohio State University
Jan 24, 2022

Multiple Sclerosis, Neurogenic Bladder Trial in Lubbock (vaginal estriol)

Completed
Has Results
  • Multiple Sclerosis
  • Neurogenic Bladder
  • vaginal estriol
  • Lubbock, Texas
    Texas Tech University Health Sciences Center
Aug 25, 2022

Exercise on Contactin-1 and Contactin-2 Level in Persons With

Completed
  • Relapsing Remitting Multiple Sclerosis
    • Elazığ, Turkey
      Fırat university
    Apr 22, 2022

    Quality of Life in Clinical Practice in Germany for

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
      • Dresden, Saxony, Germany
        Universitätsklinikum Dresden, MS Ambulanz
      Apr 12, 2022